ReviewInfection and drug resistance2026
Strategies for Managing Marburg Virus Disease Outbreaks: Lessons from the Rwanda Outbreak.
Review in Infection and drug resistance, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Marburg Virus Disease (MVD) is a highly lethal viral hemorrhagic fever caused by the Marburg virus, a member of the filovirus family closely related to Ebola. Characterized by sudden onset of fever, hemorrhage, and multi-organ failure, MVD outbreaks pose significant public health challenges due to high mortality rates and limited medical countermeasures. The 2024 outbreak in Rwanda marked a critical point, with 66 confirmed cases and 15 fatalities, highlighting the urgent need for effective management strategies. This narrative review, reviews key lessons from Rwanda's response, emphasizing the critical importance of early detection through strengthened surveillance systems and rapid diagnostics, implementation of strict infection control practices, and robust community engagement to foster trust and cooperation. Rwanda's integrated approach, including supportive clinical care, innovative use of therapeutics, and swift deployment of investigational vaccines, illustrates effective outbreak containment. The study underscores the necessity of resilient health infrastructure, ongoing research, and Cross-border collaborations in mitigating future threats. Insights from Rwanda's recent experience provide valuable guidance for global preparedness and response strategies to contain and manage future Marburg outbreaks effectively.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.